EUVIMEDEUVIMED entdecken
Crossref

3‐Deoxy‐3β‐syringoylamino‐betulinic acid Reduces Breast Tumor Growth and Lung Colonization, With Associated Downregulation of the RAS/RAF/MEK/ERK Pathway

Hu Liu, Pei-Wen Su, Hui Song, Chao Wang, Peipei Shan, Hua Zhang iD

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.202502436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Hu Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, University of Jinan, Jinan, China. Hauptthemen laut MEDLINE: Breast Neoplasms, MAP Kinase Signaling System, Antineoplastic Agents, Triterpenes. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Betulinic acid (BA) and its structural derivatives/analogs exhibit diverse biological activities particularly antitumor property, which has established them as attractive research topics in recent years. In the present work, 33 3‐substituted BA derivatives comprising 13 previously unreported ones were synthesized. Among them, a syringoyl analog (3‐deoxy‐3β‐syringoylamino‐betulinic acid [DSABA]) showed significantly enhanced cytostatic activity against specific tumor cell lines. Further in vitro antitumor evaluation revealed that DSABA induced cell death and G 0 /G 1 phase arrest, as well as inhibited the migration and invasion, of two breast cancer cell lines, and the in vivo antitumor efficacy was subsequently validated in an orthotopic autograft mouse model. Mechanistically, DSABA may exert its antitumor effect by modulating the RAS/RAF/MEK/ERK signaling pathway, as evidenced by a series of in vitro and in vivo experiments. In conclusion, this study has identified DSABA as a promising antitumor candidate, providing a foundation for the future investigation of related structural analogs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMAP Kinase Signaling SystemAntineoplastic AgentsTriterpenesLung NeoplasmsAnimalsHumansFemaleMiceCell Proliferationras Proteinsraf KinasesDown-RegulationPentacyclic TriterpenesDrug Screening Assays, AntitumorCell Line, TumorBetulinic AcidStructure-Activity RelationshipDose-Response Relationship, DrugMolecular StructureMice, Inbred BALB CMice, NudeCell Movement

Stichwörter der Autor:innen

MAPK signalingRAS/RAF/MEK/ERKantitumorbetulinic acidbreast cancerstructural modification

Substanzen

ras Proteinsraf KinasesPentacyclic TriterpenesAntineoplastic AgentsTriterpenesBetulinic Acid

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, University of Jinan, Jinan, China.
  • School of Biological Science and Technology, University of Jinan, Jinan, China.
  • Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, Qingdao Medical College, Qingdao University, Qingdao, China.

ORCID-Profile: Hua Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, H., Su, P. W., Song, H., Wang, C., Shan, P., & Zhang, H. (2026). 3‐Deoxy‐3β‐syringoylamino‐betulinic acid Reduces Breast Tumor Growth and Lung Colonization, With Associated Downregulation of the RAS/RAF/MEK/ERK Pathway. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202502436

Vancouver

Liu H, Su PW, Song H, Wang C, Shan P, Zhang H. 3‐Deoxy‐3β‐syringoylamino‐betulinic acid Reduces Breast Tumor Growth and Lung Colonization, With Associated Downregulation of the RAS/RAF/MEK/ERK Pathway. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202502436

BibTeX
@article{Liu2026,
  author = {Liu, Hu and Su, Pei-Wen and Song, Hui and Wang, Chao and Shan, Peipei and Zhang, Hua},
  title = {3‐Deoxy‐3β‐syringoylamino‐betulinic acid Reduces Breast Tumor Growth and Lung Colonization, With Associated Downregulation of the RAS/RAF/MEK/ERK Pathway},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.202502436}
}
Kostenlos starten →